Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma [0.03%]
胶质母细胞瘤干细胞成为胶质母细胞瘤治疗的新靶点
Rasime Kalkan
Rasime Kalkan
Primary and secondary glioblastomas (GBMs) are two distinct diseases. The genetic and epigenetic background of these tumors is highly variable. The treatment procedure for these tumors is often unsuccessful because of the cellular heterogen...
Syed Hasan Raza Jafri,Carlos Previgliano,Keerti Khandelwal et al.
Syed Hasan Raza Jafri et al.
Introduction: Cancer cachexia affects many advanced non-small-cell lung cancer (NSCLC) patients. Cachexia index (CXI) was developed to assess the degree of cachexia in these patients. ...
Sharon Wilks,Kristi McIntyre
Sharon Wilks
Outcomes for triple-negative or hormone-refractory metastatic breast cancer (MBC) are poor and treatment options are limited. Described herein are cases of two women who developed MBC following adjuvant chemotherapy and endocrine therapy fo...
Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease [0.03%]
吉西他滨致肺毒性的个案报道：肺静脉阻塞性疾病
Célia Turco,Marine Jary,Stefano Kim et al.
Célia Turco et al.
Introduction: Gemcitabine is a chemotherapeutic agent frequently used by for the treatment of several malignancies both in the adjuvant and metastatic setting. Although myelosuppression is the most adverse event of this t...
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer [0.03%]
激素受体阳性晚期乳腺癌老年患者治疗
David Riseberg
David Riseberg
As the overall population ages, the proportion of elderly patients (aged ≥65 years) with breast cancer also increases. Studies have shown that elderly patients with hormone receptor-positive breast cancer can derive as much benefit from tr...
Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab [0.03%]
那他珠单抗治疗患者发生胃非霍奇金淋巴瘤1例报告
Jennie Y Law,Dong W Kim,Ariel Sturgis et al.
Jennie Y Law et al.
A 61-year-old man with relapsing-remitting multiple sclerosis developed extranodal large B-cell lymphoma of the stomach following monthly natalizumab infusions for 6 years. Development of lymphoproliferative disorders increases with chronic...
Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia [0.03%]
儿童B细胞急性淋巴细胞白血病亚型中最小残留疾病的转录组分析
Jitsuda Sitthi-Amorn,Betty Herrington,Gail Megason et al.
Jitsuda Sitthi-Amorn et al.
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer and the leading cause of cancer-related death in children and adolescents. Minimal residual disease (MRD) is a strong, independent prognostic factor. The objective of th...
Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders [0.03%]
过氧化物酶体增殖物激活受体 gamma(PPARgamma)在妇科疾病中的功能
Ping Ren,Yuquan Zhang,Yan Huang et al.
Ping Ren et al.
Peroxisome proliferator-activated receptor gamma (PPARγ) is a member of a class of nuclear hormone receptors intimately involved in the regulation of expression of myriad genes that regulate energy metabolism, cell differentiation, apoptos...
Molecular cytogenetics in childhood acute lymphoblastic leukemia: a hospital-based observational study [0.03%]
儿童急性淋巴细胞白血病分子细胞遗传学的医院基于观察性研究
Aakash Pandita,Rekha Harish,Sanjeev K Digra et al.
Aakash Pandita et al.
Objective: This study was conducted to determine the frequency of chromosomal aberrations in children aged
Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy [0.03%]
经历化疗后的转移性CRPC患者使用Ad-REIC基因治疗的 promising 结果
Hiromi Kumon,Katsumi Sasaki,Yuichi Ariyoshi et al.
Hiromi Kumon et al.
A 63-year-old man with metastatic castration-resistant prostate cancer (CRPC) was successfully treated for two years with in situ gene therapy using an adenovirus vector carrying the human REIC/Dkk-3 gene (Ad-REIC), following chemotherapy. ...